WebJun 16, 1992 · CSPC, founded in June, 1992 and headquartered in Shijiazhuang, is a biopharmaceutical developer. The founder is Cai Dongchen. Listed on the HKEX on … WebJun 15, 2024 · Sponsors: Lead Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Source: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Brief Summary: The primary objective of this trial is to evaluate the efficacy of different doses and frequencies of administration of TG103 injection in the treatment of type 2 diabetes.
CSPC Pharmaceutical Group Limited - About Us > Corporate
WebJul 27, 2024 · August 2, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. A Multi-center, Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of the Prophylactic Use of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor After Chemotherapy in Children With Hematological Malignancies WebSep 14, 2024 · September 23, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Mellitus truschke surname
Healthy Male Subjects Trial in Nanjing (TG103 produced by the …
WebOct 23, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Save Print Send. Updated on 23 October 2024. See if I qualify. Summary. Show definitions. A multicenter, open, one-arm clinical study evaluated the efficacy and safety of Jinyouli in preventing neutropenia after chemotherapy in elderly lymphoma patients who met the criteria for … WebFind company research, competitor information, contact details & financial data for CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd. of Yantai, Shandong. Get the latest business insights from Dun & Bradstreet. WebJul 27, 2024 · First Received: July 27, 2024 Last Updated: August 4, 2024. Phase: N/A Start Date: August 1, 2024. Overall Status: Unknown status Estimated Enrollment: 139 truschel timothy l. md